Tag:
Tetraphase Pharmaceuticals
Latest Headlines
Latest Headlines
Trius shares surge as antibiotic matches Zyvox in pivotal PhIII
Shares of Trius Therapeutics ( $TSRX ) surged on the news that its late-stage antibiotic tedizolid closely matched Zyvox (linezolid) in one of a series of pivotal studies, helping nail down support for
Tetraphase hauls in $45M C round to back antibiotic work
Watertown, MA-based Tetraphase Pharmaceuticals has hauled in a $45 million C round--a hefty chunk of cash that will open a development runway stretching out up to two-and-a-half years. Over that
Emerging Drug Developer: Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals Tetraphase Pharmaceuticals' roots go back to Andrew Myers' laboratory at Harvard, where the chemist--who
Tetraphase raises $15M for antibiotic work
Massachusetts-based Tetraphase Pharmaceuticals has closed the second tranche of its $25 million Series A financing. The $15 million tranche was funded by existing investors, including Mediphase
